n=4, 6,8,11,12 and 10. Phenyl diguanide, phenyl guanidine, hexamethylene dipiperide, and octamethylene di-imino ether were inactive at the concentrations tested.
For brevity, in the text, 18-methylene diamine, e.g., is referred to as 18-diamine, or as n = 18. It should be noted that since, by the above nomenclature, one carbon atom is included in the amidine group, the diamidines have n+2 and the monoamidines n+ 1 carbon atoms in an unbroken chain. The 12-diamidine, for example, is therefore compared with the 14-diamine, and the 15-amidine with the 16-amine.
Methods
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Activity in broth Sensitivity of bacteria. Bacteria differed greatly in their sensitivity to the drugs (Tables 1-4 ). For example 18-diamine inhibited Str. viridans at 1 in 7,000,000, Staph.
aureus at 1 in 200,000, B. enteritidis at 1 in 15,000 and was inactive against B. proteUs. In general, if the bacteria are arranged according to their sensitivities, the order in which they fall is roughly the same for all the drugs examined here.
The gram-positive cocci were the most sensitive with Str. viridans the most and Staph. aureus the least sensitive of the group. The gram-positive anaerobic bacilli were much more resistant than the cocci, but on the whole were more sensitive than ihe gramnegative bacilli, excepting the dysentery bacteria. Cl. oedematiens was the most and C1. welchii the least sensitive of the anaerobes. <10 <20 <10 <20 <10 <20 150 <20 <10 <20 <10 <20 18-,, <20 <20 <20 <20 <20 <20 <20 <20 <10 <20 <10 <20 15-Amidine 75 <20 100 <20 50 <20 75 <20 50 <20 <10 <20 17-,, <20 <10 <20 <10 <20 <10 50 <10 <20 <20 <20 <20 9- Guanidine   75  50  60  40  30  20 100  50  20  5  20   5  14-,,  300 <10 200 <10 100 <10 150  20  30 <10 <10 <10  16-,, <20 <10 <20 <20 <20 <10 100 <10 <20 <10 <20 <10 18-,, <20 <10 <20 <20 <20 <20 <20 <20 <20 <20 <20 <20 
typhi-murium (sub-group B).
A few of the drugs differ markedly in their actions towards gram-positive and gramnegative bacteria. For example, the 16-and 18-amines and guanidines were very active against gram-positive, but were inactive against gram-negative bacteria, except B. cholerae and pasteurella. These last two were similar also in being much more sensitive than the other gram-negative bacilli to 18-quaternary base. The diamines were much more active against gram-positive than against gram-negative bacteria, both in actual titres and in comparison with the other drugs. The dysentery strains were unusually resistant to the diamines and di-isothioureas, but were sensitive to the more powerfully basic diguanidines and quaternary salts.
CHEMOTHERAPY OF ALIPHATIC BASES Effect of chain length. The activity in all the series of drugs (except the di-isothioureas) increased with the length of the carbon chain up to n= 14 to 18 for the disubstituted compounds and up to n-12 to 16 for the monosubstituted compounds. The diamine and diamidine series had not reached maximal activity against gram-positive organisms by n= 18, but with this exception the series had reached a stationary or a declining phase before this point. In the disubstituted series the' fall in activity with increasing chain length beyond the optimal was gradual, but in the monosubstituted series the. fall was much sharper, especially against gram-negative bacteria. Thus the drugs of the monosubstituted series with n= 16 or more were inactive against practically all the gramnegative bacteria, although they were potent against the gram-positives.
The diguanidines reached their maximum activity at a shorter chain length than the diamiines or diamidines, but the reverse held in the monosubstituted series.
Stilbene-diamidine, which includes two benzene rings, had approximately the activity of the n= 12 open chain compound.
The rates of change of activity varied greatly in the different series. There was sometimes a 20-to 30-fold increase of titre for an addition of 2n, as for example from 12-to 14-diguanidine against the cocci, but in general the changes were more gradual.
Drugs of chain length lower than n = 8 had very slight activity except in the diisothiourea series, the activity of which increased and decreased sharply as the series was ascended. ' Effect of the terminal group. The effects of mono-or di-substitution, and of changes in the end groups can be seen by comparing compounds of the same chain length. The disubstituted guanidines were far more active than the monosubstituted against all bacteria. In the other series the monosubstituted compounds had, on the whole, a slight advantage, especially against the anaerobes and the colon-typhoid group. The monosubstituted series reached maximum activity at a shorter chain length than the disubstituted, which gave the higher members of the latter a great advantage, especially against gram-negative bacteria.
The di-isothioureas appeared to be by far the most active at chain lengths of 4 and 6, while the diguanidines were, with few exceptions, the most active from n= 10 to n = 18.
The advantage of the diguanidines became'less as the chain length increased.
The diamines were more active than the diamidines and much more active than the quaternary bases. The activities in the diamine and diamidine series started to decrease at a shorter chain length against gram-negative than against gram-positive bacteria, but the opposite was true in the diguanidine series. The guanidines were the most active in the monosubstituted series, but had not the overwhelming superiority of the diguanidines. The comparison between the strongly basic qiuaternary bases and the weakly basic amines *was incomplete, and a more complete comparison would be interesting. The 8-di-quaternary salt was similar in activity to the 6-diamine. The 9 mono-and the 14-di-quaternary salts were much less active, and the 18-mono-more active than the corresponding amines.
Effect of serum Table 5 shows how the activities of the drugs against different classes of bacteria were affected by the presence of serum. It has the disadvantage that bacteria behaving differently have been grouped together, but the influence of serum on individual strains can be seen in Tables 1-4. Besides its direct effect on the drug, serum affects the titres by obscuri'ng small amounts of growth in the opalescent serum, and by its effect on the growth-rate of some bacteria. Di8ubstituted drugs. Serum caused an increase in the activity of the lowest members of the disubstituted series, except in the di-isothiourea group and against Str. pyogenes.
As the chain length increased, this advantage steadily decreased until at n 16 or 18, 553 the drug had only a fraction of its activity in broth (Table 5) . Thus maximal activity occurred at a shorter chain length in serum than in broth.
Against staphylococcus, B. shigae and B. typhosum the ratios of serum to broth activities (S/B) varied from 5 to 13 for the shortest chains, falling steadily to unity or less for the longest chains. With Str. viridans, pneumococcus, pasteurella and the anaerobes, serum interfered more, so that the values were seldom over unity even for the short chains, and fell further as the chain lengthened. Other organisms were intermediate in their behaviour. The activity against Str. viridans was the most depressed of any, possibly owing to the growth stimulation produced by serum on broth cultures of this organism. With Str. pyogenes, serum weakened drugs with chain lengths below n= 10 and above n= 14, and strengthened the middle members. In the di-isothiourea group the least active compounds were strengthened, and the most active weakened, so that in serum there was a resultant increase of activity with chain length.
Serum activated the diamidine series against Str. pyogenes and staphylococcus. On the other hand the diamidines were very much weakened against the anaerobes and the diisothioureas against staphylococcus. The great sensitivity of B. shigae to the diamidines and diguanidines in serum is striking.
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Monosubstituted drugs. These were much more strongly inhibited by serum than the corresponding members of the disubstituted series, and the point of serious interference occurred at a shorter chain length. Only in the 9-amine and 9-quaternary salt was an increase in activity in serum observed, and by n =12 the activity was only about 10 % of the activity in broth. Consequently the higher mono-amines, -amidines and -guanidines were inactive against all organisms except some cocci. 9-Amine and 9-guanidine were equally active against gram-positive, but the guanidine was by far the more potent against gram-negative bacteria.
Titres in serum. It will be seen from Tables 1-4 that the diguanidines came out best of the disubstituted serics against all bacteria, especially the gram-negative ones. The 14-and 16-diamines and 16-diamidine also were prominently active. The higher diamines were the most active against Str. viridans and anaerobes, the higher diamidines against Str. pyogenes and Staph. aureus, and the higher diamidines and diguanidines against dysentery. In the monosubstituted series, the guanidines were best against Str. pyogenes, Staph. aure,us and gram-negative organisms. No compound with chain length above n= 14 was active against any Qf these last. The higher amidines were best against Str. viridans, and the amines against the anaerobes. 9-Quaternary base was unusually active against Str.
pyogenes.
Although the activities of some drugs were increased 10-fold against B. shigae and Str. pyogenes, serum interfered most seriously with the most active drugs, and this limited the peak activity of any series. For example, the activity of 4-di-isothiourea against Str. viridans was reduced from 1 in 1,000,000 to 1 in 10,000, and that of 12-amine against pneumococcus from 1 in 7,000,000 to 1 in 10,000.
Serum caused some change in the order of sensitivity of the bacteria. Str. pyogenes .became the most and pneumococcus the least sensitive of the cocci. Cl. oedematiens remained the most sensitive of the anaerobes. B. shigae was by far the most sensitive of the gram-negative organisms, and B. typhosum next.
Strain variation
The above work had been carried out with one strain onlyoof each species and it was possible that considerable strain variations might occur. To get some idea of possible strain variation, the experiments with some of the drugs were carried out on the following 25 The variation in the inhibitory titres for the Flexner strains can be seen from Table 6 . They are for the most part inconsiderable, especially as the results were not checked as thoroughly as in the main series. A. T. FULLER Sulphanilamide-resistant strains. Three group A streptococcus pyogenes strains, 'Mead', 'Kingsbury', and 'Atkinson', resistant to sulphanilamide,-and two other sensitive strains, 'Pickering' and 'Wood' were tested. They were recently isolated fromwounds and were kindly supplied by Dr Colebrook. The results ( Table. 7) show that resistance to sulphanilamide does not affect the sensitivity to the present series of drugs. The titres were not determined as exhaustively as in the main series and the differences were probably not as great as indicated in Table 7 . Therapeutic effect King et al. [1938] determined the toxicities of the drugs, which have a mouse-tolerated dose of 1-4 mg. for the lowest members and 0-1-0-5 mg. for the higher members. 18-Amine and 18-guanidine are less toxic than the lower members.
Multiplying the 50 % serum titres of the drugs by the mouse-tolerated doses gives a measure of their probable therapeutic efficiencies, so far as these can be deduced from in vitro testing. Compounds giving high values are 14-diamine, 14-diamidine and 14-guanidine. 11-Di-isothiourea is the best of its group, especially against gram-negative bacteria; 9-and 12-amines are the best of the monosubstituted compounds.
Dr F. Hawking kindly tested some of these compounds in mice infected intraperitoneally with Str. pyogenes, 'Richards'. The drugs were given subcutaneously twice a day for 3 days, and once a day for the next 3 days, in the doses per g. of mouse given below. NQ significant therapeutic effect was obtained. 
DiscuSSION
In vitro antibacterial power is the most important single factor in the activity of the chemotherapeutic drugs in use to-day, and the in vitro technique, by its speed and precision, is of use in investigating new drugs.' It was hoped, by using a large range of bacteria, and several series of related drugs, to discover some of the underlying principles CHEMOTHERAPY OF ALIPHATIC BASES of drug specificity. This, unfortunately, has not been possible, but the antibacterial action of the present series is worth recording.
The chief feature is the increase of activity with chain length up to a certain point, followed by a decrease beyond that point. The exception to this rule is the curious alternation of compounds with high and low' activity in the di-isothioureas, and the potency of the lowest member. This series differs from the others in having sulphur atoms in the carbon chain. Baker, Harrison &; Miller [1941] found that the straight-chain alkyl sulphates had maximum antibacterial activity' at 12-16 carbon atoms.
The increase of activity with chain length suggests that surface-active properties may be responsible for the activity of these compounds' and that they may act by denaturing some essential protein constituent [Anson, 1939] .. It would be interesting to determine the effect of branched chain derivatives, or those having more than two active centres, since alkyl sulphates of this type are very powerfully surface-active [Caryl & Ericks, 1939] .
Being basic, the drugs may combine with a bacterial protein, e.g. a nucleoprotein, and render it inert; this is supported by the fact that the most active compounds tend to be'the most toxic and the most inhibited by serum. Serum may act by affecting the adsorption of the drug by the bacteria.
The bacteriostatic titres are much lower than the trypanocidal titres, but the variations of activity with chain length are similar in both cases. It is probable that the same mechanism is responsible for both actions of the drugs, and that these may be general protoplasmic poisons.
Taking the results as a whole, the differences in activity caused by interchange of the end groups are not large. The chain length is usually far more important than the end group. The basicity of these groups presumably increases in the following order-diisothioureas, amines, amidines, guanidines and quaternary ammonium salts. It does not appear that activity depends on a particular balance between the chain length and the basicity of the end groups. A more complete comparison between the amines and the quaternary salts would be interesting in view of the great difference in basicity between them.
The disubstituted drugs are on the whole more satisfactory than the monosubstituted. The higher members are more active at equal chain length and are far less inhibited by serum, but are more toxic.
One -generalization which can be made is that the less strongly'basic amines have a relatively stronger action on.the gram-positive bacteria while the strongly basic guanidines and quaternary bases have* a relatively stronger action on the gram-negative organisms. This is very marked in the dysentery group, against which the diamines and di-isothioureas are weakly active, and the corresponding amidines, guanidines and quaternary bases relatively stronger. This holds for both the mono-and di-substituted series, and it would appear that increasing the basicity of the end groups is likely to make the compound more active against gram-negative and relatively less active against grampositive organisms.
If the bacteria are arranged according to sensitivity to the drugs, the order in which they fall is broadly similar to that for the sulphonamides, i.e. those of greatest metabolic activity are the most resistant. Small differences occur, e.g. ca. oedematiens is the most sensitive of the anaerobes to.the present series, whereas it is the most resistant to the sulphonamides. The present series too are active in much higher dilution, and are powerfully bacteriostatic in media (broth and serum-broth) in which the sulphonamides have little action. Although the activity of the drugs in broth is considerable, their high toxicity and the interference of serum with the most active are against their chemotherapeutic use, and Dr Hawking's tests show them to be inactive.against Str. pyogene8.
In this they resemble gramicidin [Dubos & Hotchkiss, 1941] which is active in the body 557, 558 A. T. FULLER only when applied locally. White, Bratton, Litchfield & Marshall [1941] have found that many substances active in vitro are without,therapeutic effect. The drugs might be useful for local application against sulphonamide-resistant organisms; and the very sparing solubility of the free bases might confer advantages in the treatment of enteric infections.' SUMMARY The antibacterial activity of straight-chain co-mono-and di-amines, amidines, guanidines and quaternary bases in broth increases with chain length up to a maximum and then decreases. The corresponding changes in the di-isothioureas are irregular.
Gram-positive organisms are on the whole more sensitive than gram-negative, and the bacteria fall roughly in the same order for related drugs.
Serum usually causes an increase in the activity of the shorter-chain and a decrease in that ofthe longer-chain diugs. This effect, however, varies with the bacteria concerned, and it causes maximum activity in a series to occur at a shorter chain length than in broth. The drugs are active against sulphanilamide-resistant haemolytic streptococci, but have notherapeutic action when applied systemically.
My thanks are due to Dr Harold King for supplying the drugs, and to Dr Colebrook for the strains, and to both for advice generously given. I am also indebted to Dr A. N.
Drury for a supply of human serum, and to Dr F. Hawking for carryiing out animal tests.
